Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
9.20
+0.62 (7.23%)
At close: Oct 28, 2026, 4:00 PM EDT
8.92
-0.28 (-3.04%)
After-hours: Oct 28, 2026, 7:30 PM EDT
Akari Therapeutics, Market Cap
Akari Therapeutics, has a market cap or net worth of $21.02 million as of October 28, 2026. It is the 36,495th most valuable company in the world and the 5,171st biggest in the United States. Its market cap has decreased by 25.94% in one year.
Market Cap
21.02M
Enterprise Value
14.02M
1-Year Change
-25.94%
Global Rank
Country Rank
#5,171 United States
Category
ChartMarket Cap Chart
Since September 28, 2015, Akari Therapeutics,'s market cap has decreased from $291.48M to $21.02M, a decrease of -92.79%. That is a compound annual growth rate of -21.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 21.02M | 58.89% |
| Dec 31, 2025 | 13.23M | -59.03% |
| Dec 31, 2024 | 32.30M | 83.11% |
| Dec 29, 2023 | 17.64M | -49.58% |
| Dec 30, 2022 | 34.98M | -51.00% |
| Dec 31, 2021 | 71.40M | 0.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immutep | 23.17M |
| Context Therapeutics | 21.56M |
| Polyrizon | 20.84M |
| Quantum BioPharma | 19.65M |
| Quoin Pharmaceuticals | 19.46M |
| BeyondSpring | 19.00M |
| Cocrystal Pharma | 18.90M |
| Neuphoria Therapeutics | 18.34M |